Inhibitory effects of SY0916, a platelet-activating factor receptor antagonist, on the angiogenesis of human umbilical vascular endothelial cells

By Wu Lian-Qiu   OuYang Xue-Yu   Liu Yang   Peng Shan-Ying   Wang Lin   Wang Wen-Jie  

Journal of Asian Natural Products Research, Vol. 13, Iss. 11, 2011-10 ,pp. : 984-992

Taylor & Francis Ltd

Access to resources Recommend Favorite

Ocular actions of platelet-activating factor: clinical implications

By Nitoda Eirini   Moschos Marilita M   Mavragani Clio P   Koutsilieris Michael  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 10, 2012-10 ,pp. : 1027-1039

Informa Healthcare

Access to resources Recommend Favorite

Current status of platelet-activating factor antagonists

By Curtin M.L.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 6, 1998-06 ,pp. : 703-711

Informa Healthcare

Access to resources Recommend Favorite

Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models

By Fukuda Y.   Kawashima H.   Saito K.   Inomata N.   Matsui M.   Nakanishi T.  

European Journal of Pharmacology, Vol. 390, Iss. 1, 2000-02 ,pp. : 203-207

Elsevier

Access to resources Recommend Favorite

Expression, secretion, and inhibition of angiotensin-converting enzyme in cultured human bronchial epithelial cells

By Takimoto M.   Mitani H.   Hori S.   Kimura M.   Bandoh T.   Okada T.  

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 169-177

Elsevier

Access to resources Recommend Favorite